Quincy Siu-Chung Chu

14PUBLICATIONS
115CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 26, 2026
ENTRÉE Lung: An Open-label Platform Study Investigating the Safety and Pharmacokinetics of Belrestotug Combinations in Advanced Non-Small Cell Lung Cancer.

|Oct 23, 2026
Patients' lived experiences of fractures during immune checkpoint inhibitor therapy: a qualitative study.

|Aug 28, 2026
Perioperative Durvalumab for Resectable Non-Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial.

|Aug 05, 2025
Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors.

Funda Meric-Bernstam, Martin Gutierrez, Enrique Sanz-Garcia

|May 12, 2025
Xevinapant plus avelumab in advanced solid tumours, with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker, safety and efficacy analyses from an open-label, nonrandomised phase Ib study.

Glenwood Goss, Tudor Ciuleanu, Rodryg Ramlau

|Apr 23, 2025
Cost-Effectiveness of Adjuvant Alectinib Versus Chemotherapy for Patients with Resectable, ALK-positive Non-small Cell Lung Cancer in Canada.

Nick Jovanoski, Sarah Vaselenak, Andrew Hogan

Pageof 3

Frequent Collaborators

2 joint publications

Barbara Melosky

2 joint publications

Giuseppe Curigliano

1 joint publications

Roy S Herbst

1 joint publications

Alfredo Sanchez-Hernandez